Management of malignant pleural effusion
JA Kastelik - Lung, 2013 - Springer
Malignancy is one of the most common causes of pleural effusion. Malignant pleural effusion
is defined by the presence of malignant cells in the pleural fluid. Development of malignant …
is defined by the presence of malignant cells in the pleural fluid. Development of malignant …
Diagnostic accuracy of combinations of tumor markers for malignant pleural effusion: an updated meta-analysis
Y Yang, YL Liu, HZ Shi - Respiration, 2017 - karger.com
Background: The role of combinations of tumor markers such as carcinoembryonic antigen
(CEA), carbohydrate antigens (CA) 125, 15-3, and 19-9, and CYFRA 21-1 (a fragment of …
(CEA), carbohydrate antigens (CA) 125, 15-3, and 19-9, and CYFRA 21-1 (a fragment of …
Thymidine kinase 1 combined with CEA, CYFRA21-1 and NSE improved its diagnostic value for lung cancer
ZF Jiang, M Wang, JL Xu - Life sciences, 2018 - Elsevier
Abstract Aims Thymidine kinase 1 (TK1) is a tumor biomarker in human malignancies. The
purpose of this study was to evaluate the diagnostic efficiency of this marker for lung cancer …
purpose of this study was to evaluate the diagnostic efficiency of this marker for lung cancer …
CEA, AFP, CA125, CA153 and CA199 in malignant pleural effusions predict the cause
XF Wang, YH Wu, MS Wang… - Asian Pacific Journal of …, 2014 - koreascience.kr
Determination of the cause of malignant pleural effusions is important for treatment and
management, especially in cases of unknown primaries. There are limited biomarkers …
management, especially in cases of unknown primaries. There are limited biomarkers …
Diagnosis and treatment of malignant pleural effusion: a systematic literature review and new approaches
G Lombardi, F Zustovich, MO Nicoletto… - American Journal of …, 2010 - journals.lww.com
Malignant pleural effusion is a frequent complication in many types of tumors, and its
presence indicates short expected survival. This review updates the current knowledge …
presence indicates short expected survival. This review updates the current knowledge …
Pleural fluid tumour markers in malignant pleural effusion with inconclusive cytologic results
Background: The presence of tumour cells in pleural fluid or tissue defines an effusion as
malignant. Cytology analysis of the pleural fluid has about 60% diagnostic sensitivity …
malignant. Cytology analysis of the pleural fluid has about 60% diagnostic sensitivity …
Exosomal microRNA expression profiling in patients with lung adenocarcinoma-associated malignant pleural effusion
H Tamiya, A Mitani, A Saito, T Ishimori… - Anticancer …, 2018 - ar.iiarjournals.org
Background/Aim: Cytological analysis for diagnosing malignant pleural effusion associated
with lung adenocarcinoma (Ad-MPE) shows limited sensitivity and novel diagnostic …
with lung adenocarcinoma (Ad-MPE) shows limited sensitivity and novel diagnostic …
[HTML][HTML] Diagnostic value of six tumor markers for malignant pleural effusion in 1,230 patients: a single-center retrospective study
X Fan, Y Liu, Z Liang, S Wang, J Yang… - Pathology and Oncology …, 2022 - por-journal.com
Background: The diagnostic value of tumor markers in pleural effusion (PE) and serum for
malignant pleural effusion (MPE) was still in debate. The study aimed to evaluate the …
malignant pleural effusion (MPE) was still in debate. The study aimed to evaluate the …
Pleural CEA, CA-15-3, CYFRA 21-1, CA-19-9, CA-125 discriminating malignant from benign pleural effusions: Diagnostic cancer biomarkers
F Fazli Khalaf, M Asadi Gharabaghi… - The International …, 2023 - journals.sagepub.com
Introduction There is a need for a rapid, accurate, less-invasive approach to distinguishing
malignant from benign pleural effusions. We investigated the diagnostic value of five pleural …
malignant from benign pleural effusions. We investigated the diagnostic value of five pleural …
Body fluid analysis: clinical utility and applicability of published studies to guide interpretation of today's laboratory testing in serous fluids
DR Block, A Algeciras-Schimnich - Critical reviews in clinical …, 2013 - Taylor & Francis
Requests for testing various analytes in serous fluids (eg pleural, peritoneal, pericardial
effusions) are submitted daily to clinical laboratories. Testing of these fluids deviates from …
effusions) are submitted daily to clinical laboratories. Testing of these fluids deviates from …